Just analyzing revenue amounts as a % year over year and Canopy growth saw a 400% increase in YOY revenue from 2015 to 2016. Impressive as a standalone accomplishment.
But that's just the beginning. If they come in with $23 million in the 4th quarter due out 3rd week of June, which I believe is just over consensus, then guess what! 400% increase YOY from 2016 to 2017.
Canopy's quarters are consistently growing obviously so the 4 quarters in Fiscal 2018 (April 2017 - April 2018) will all be minimum $25 million especially considering they are full quarters with Mettrum sales. Now add in a full year of German medical sales prescribed by German doctors and paid by the German government and I don't believe that it's a stretch to see us get to $180 million.
That would put us at the 3rd consecutive year of YOY 400% growth! Which brings us to April 2018, I'm sure I don't need to tell anyone what Fiscal 2019 brings (Canadian Rec sales). Canadian Rec sales and European expansion will put us in a great position for our potential 4th consecutive 400% YOY increase.
All these posts recently about Canopy spreading itself too thin and being over priced and heading back to $2. It's all just noise. The time of getting share price bumps for POTENTIAL CATALYSTS is over. This market wants to see one thing and one thing only now.......Results.
Having 4 Fiscal 400% YOY increases is going to open some eyes big time and draw a lot of attention. I think you'd be hard pressed to find another company in history that was able to consistently have that growth for 4 straight years.
Time will tell if I'm right, and I believe that I am. Share price will be now where near $10 when this happens... and it will all play out by June 2019 which will mark the results of the last of the 4 years
